About this trial
This is a prospective, multicenter observational cohort study involving approximately 2,700 patients, designed to delineate the natural history of pneumonia by tracking the complete clinical course and dynamic multi-omics evolution from the acute phase to recovery; the study aims to quantify severe conversion rates and mortality by comparing baseline characteristics, pathogen distribution, and immune response trajectories between severe and non-severe groups, ultimately revealing the underlying molecular mechanisms of disease progression and optimizing clinical risk stratification strategies.
Eligibility criteria
Qualifiers
Inclusion and
Disqualifiers
Respiratory rate ≥ 30 breaths/min
PaO₂/FiO₂ ≤ 250 mm Hg
Multiple lobe infiltrates
Confusion and/or disorientation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Zhonghao Fang
Lead sponsor
Guangzhou Medical University
Sponsor institution
Fifth Affiliated Hospital of Guangzhou Medical University
Collaborator